Targeting HER2 in patients with HER2-negative metastatic breast cancer with elevated serum levels of the HER2 extracellular domain and/or HER2-positive circulating tumor cells in the clinical routine

Autor:	M.A. Warm, S. Herz, A. Quade, C.M. Kurbacher, J.A. Kurbacher, G. Kunstmann
Rok vydání:	2015
Předmět:	CA15-3 Pathology medicine.medical_specialty business.industry HER2 negative Hematology Clinical routine medicine.disease Metastatic breast cancer Elevated serum Circulating tumor cell Oncology Extracellular Cancer research medicine In patient business
Zdroj:	Annals of Oncology. 26:iii6
ISSN:	0923-7534
DOI:	10.1093/annonc/mdv115.08
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aaa27f86ccc2c1d04fbd1071b8e4cad0 https://doi.org/10.1093/annonc/mdv115.08 Zobrazit plný text záznamu